Hamilelikte methyl bimatoprost acidate kullanmaktan kaçınmalı mıyım? | VeriMom

What to use instead

Pregnancy-safe ingredients that serve a similar function:

Pregnancy-safe products to use instead

Products built around the safer ingredients above, scored "no known risks" or "low risk".

Mew mew tweet

100

Mew mew tweet Cedar Spruce Baking Soda Free

L'Occitane

100

L´Occitane Powder To-mousse Facial Exfoliator

Avero

100

Avero Solid Deodorant

Unknown

100

schmidts here now

Sustain Yourself

100

Sustain Yourself Natural Deodorant

Bitamin

100

Bitamin Natural Deodorant N'orange

Dr Teals's

99

Dr Teals's Aluminum Free Deodorant Charcoal

900care

99

Déodorant stick parfum embruns

HappySoaps

99

Happysoaps Neutraal

Routine

99

Routine The Curator

Hamilelikte methyl bimatoprost acidate yerine kullanılabilecek güvenli alternatifler | VeriMom

İçerikler — İçerikler

Ayrıca bakın

• methyl bimatoprost acidate hamilelikte güvenli mi?
• methyl bimatoprost acidate bebekler için güvenli mi?
• methyl bimatoprost acidate için hamilelikte güvenli alternatifler nelerdir?

FAQ

methyl bimatoprost acidate hamilelikte güvenli mi?

H361 (‘suspected of damaging fertility or the unborn child’) is reported for this substance in supplier/EU SDS/C&L‑type entries and the SCCS included methyl bimatoprost acidate among prostaglandin analogues of concern for cosmetic use; animal reproductive studies with bimatoprost show abortion, increased resorptions and post‑natal pup effects at high doses, and the Latisse/Lumigan product label advises caution in pregnancy. These facts support h=2 (suspected). Mechanistically, prostaglandin analogues have demonstrated reproductive/developmental effects in animal studies (m=2). Systemic absorption from topical/ocular application is low but measurable, so exposure from cosmetic topical use is low but real (e=1). Sources: SCCS opinion, FDA/LATISSE label, supplier SDS.

methyl bimatoprost acidate emzirirken güvenli mi?

Supplier safety data and regulatory/product labels record H362 (may cause harm to breast‑fed children) and state bimatoprost is excreted in milk in animal studies. Given the parent drug is excreted in milk (per product labels) and the substance is classed with H362 in SDSs, h=2 is appropriate. Mechanism evidence (excretion into milk, documented neonatal effects in animal studies) supports m=2. Exposure by topical cosmetic use is low but measurable (e=1). Sources: FDA/LATISSE label, supplier SDSs.

methyl bimatoprost acidate bebek cildi için güvenli mi?

Do not increase hazard (h) or mechanism (m) absent infant‑specific data; retain h=2 and m=2 because the substance is a prostaglandin analogue with suspected reproductive/lactation hazards. Increase exposure (e) by +1 for baby skin per instructions because infant skin is more permeable and systemic exposure from topical application is measurable — therefore e=2 for 0–3‑year‑old skin. Sources: SCCS opinion, FDA product label, supplier SDSs.

VeriMom methyl bimatoprost acidate nasıl puanlıyor?

VeriMom methyl bimatoprost acidate'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 20/100 (yüksek risk) olarak puanlar.

Hamilelikte methyl bimatoprost acidate yerine neler kullanılabilir?

Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.